Company news

Trevi Therapeutics, Inc. news in 2026

Trevi Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026

November 2, 2026

Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference

October 27, 2026

Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting

October 13, 2026

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

August 26, 2026

Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

August 6, 2026

Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

August 6, 2026

Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

July 30, 2026

Trevi Therapeutics Announces Upcoming June and July Event Schedule

June 17, 2026

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

May 5, 2026

Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

April 29, 2026

Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

April 28, 2026

Trevi Therapeutics to Participate in Upcoming May Events

April 23, 2026

Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

April 20, 2026

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

April 16, 2026

Trevi Therapeutics to Participate in Upcoming Events

March 31, 2026

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

March 16, 2026

Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026

March 9, 2026

Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough

March 8, 2026

Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 17, 2026

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)

January 22, 2026

Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

January 8, 2026

Calls in 2026

Decks in 2026